We collected one human ccRCC sample, confirmed the VHL gene deficiency and HIF2α activation by genomic sequencing (data not shown) and IHC (Supplementary Fig. S2h), respectively, and then established the VHL mutant ccRCC PDO and Mini-PDX platforms (Fig. 2g). The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.